Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aker BioMarine ASA's EBIT per Share for the
six
months ended in Jun. 2026 was €0.07.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €0.13.
During the past 3 years, the average EBIT per Share Growth Rate was -11.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Aker BioMarine ASA's EBIT per Share or its related term are showing as below:
FRA:1PG'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -44.6 Med: 41.85 Max: 115.9
Current: -11.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Aker BioMarine ASA was 115.90% per year. The lowest was -44.60% per year. And the median was 41.85% per year.
FRA:1PG's 3-Year EBIT Growth Rate is ranked worse than 78.21% of 1583
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs FRA:1PG: -11.80
Aker BioMarine ASA (FRA:1PG) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Aker BioMarine ASA EBIT per Share Related Terms
Aker BioMarine ASA EBIT per Share Historical Data
* Premium members only.
The historical data trend for Aker BioMarine ASA's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aker BioMarine ASA (FRA:1PG) has a EBIT per Share of €0.13 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Aker BioMarine ASA and its competitors. According to the industry distribution chart, Aker BioMarine ASA ranks #1238 out of 1583 companies in the Consumer Packaged Goods industry, placing it in the top 78.2%.
Is Aker BioMarine ASA's EBIT per Share too high?
Aker BioMarine ASA's current EBIT per Share is €0.13. Based on the distribution chart, Aker BioMarine ASA ranks #1238 out of 1583 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Aker BioMarine ASA has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's EBIT per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Aker BioMarine ASA ranks #1238 out of 1583 companies for EBIT per Share. This places Aker BioMarine ASA in the lower half of its industry. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,583 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Aker BioMarine ASA and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aker BioMarine ASA's current EBIT per Share is €0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (FRA:1PG) is currently considered Significantly Overvalued. The stock's GF Value™ is €6.45, compared to a current price of €9.89 — trading 53.3% above its estimated fair value. The current EBIT per Share is €0.13. Aker BioMarine ASA's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Aker BioMarine ASA (FRA:1PG), the current EBIT per Share is €0.13 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aker BioMarine ASA (FRA:1PG) Overvalued in 2026?
Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued.
The current stock price of €9.89 is trading 53.3% above its estimated GF Value™ of €6.45.
GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.
Key valuation signals for FRA:1PG:
EBIT per Share: €0.13
GF Value™: €6.45 vs. price of €9.89 (53.3% above fair value)
No single metric tells the full story. See the FRA:1PG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
63GF Score
Get the complete analysis for FRA:1PG
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1PG has been successfully added to your 
